Found 3 clinical trials
-
Unknown Phase
-
Accepting Seniors
-
Accepting adults
-
An observational study
-
For all genders
-
Currently Recruiting
Observational Study in HCV Chronic Infection
treatment interruption in approximately 30% of cases. The recent association of first generation HCV- specific direct-acting antiviral agents (DAAs) (telaprevir and boceprevir) to standard
- 14 views
- 08 Nov, 2020
- 1 location
-
Unknown Phase
-
Accepting Seniors
-
Accepting adults
-
1000s of participants
-
An observational study
-
For all genders
-
Currently Recruiting
Efficacy and Safety of Therapy Against HCV Based on Direct-acting Antivirals in Real-life Conditions
Objectives: 1) To evaluate la proportion of hepatitic C virus (HCV)-monoinfected patients who show sustained virologic response (SVR) to treatment including direct-acting antivirals (DAAs) in the clinical practice in clinical units that treat infectious diseases and 2) to determine the frequency of adverse events, including those that are severe and/or …
- 10 views
- 08 Nov, 2020
- 1 location
-
Unknown Phase
-
Accepting Seniors
-
Accepting adults
-
1000s of participants
-
An observational study
-
For all genders
-
Pediatrics/Neonatology
-
Currently Recruiting
Real-life Security and Efficacy of DAA-based Therapy in HCV/HIV-Coinfected Patients
The purpose of this study is to evaluate the efficacy and tolerability of DAA-based regimens in the clinical practice in HIV/HCV-coinfected patients. Hypothesis: The efficacy and tolerability of DAA-based regimens in the clinical practice is different to what is observed in clinical trials in HIV/HCV-coinfected patients.
- 14 views
- 08 Nov, 2020
- 1 location